CIBC Private Wealth Group
NAMSW icon

CIBC Private Wealth Group’s NewAmsterdam Pharma Warrant NAMSW Stock Holding History

CIBC Private Wealth Group’s Portfolio NAMSW Stock Details NAMSW Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q4 		$25.3K Sell
1,000
-250
-20% -$6.2K ﹤0.01% 2080
2025
Q3 		$22.4K Sell
1,250
-1,750
-58% -$22.5K ﹤0.01% 2114
2025
Q2 		$24.2K Buy
3,000
+2,000
+200% +$16.6K ﹤0.01% 1946
2025
Q1 		$6.15K Hold
1,000
– – ﹤0.01% 2400
2024
Q4 		$14.3K Hold
1,000
– – ﹤0.01% 2162
2024
Q3 		$7.13K Hold
1,000
– – ﹤0.01% 2497
2024
Q2 		$10.3K Hold
1,000
– – ﹤0.01% 2285
2024
Q1 		$11.3K Buy
+1,000
New +$9.1K ﹤0.01% 2229

Other funds holding NAMSW

FLSM
Frazier Life Sciences Management Palo Alto, California $3.89B AUM 201.1% 1-Year Est. Return
RCM
RA Capital Management Boston, Massachusetts $9.44B AUM 157.3% 1-Year Est. Return
AAA
Affinity Asset Advisors New York $1.94B AUM 374.45% 1-Year Est. Return
BCLSI
Bain Capital Life Sciences Investors Boston, Massachusetts $1.11B AUM 171.34% 1-Year Est. Return
DM
Deerfield Management New York $8.48B AUM 99.04% 1-Year Est. Return
AC
Aristeia Capital Greenwich, Connecticut $4.82B AUM 24.91% 1-Year Est. Return
VI
Vestcor Inc Fredericton, New Brunswick, Canada $3.63B AUM 21.49% 1-Year Est. Return
UBS Group
UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return

CIBC Private Wealth Group's NAMSW Position: Q4 2025 in Review

CIBC Private Wealth Group reduced its NewAmsterdam Pharma Warrant (NAMSW) stake by 20% in Q4 2025, selling an estimated $6.2K and leaving 1,000 shares worth $25.3K. The position accounts for ﹤0.01% of the portfolio, ranked #2080.

CIBC Private Wealth Group first reported a position in NAMSW in Q1 2024 and has held it in 8 quarters since. 9 funds tracked by Wall St. Rank hold NAMSW as of Q4 2025.

  • CIBC Private Wealth Group held 1,000 shares of NewAmsterdam Pharma Warrant worth $25.3K as of Q4 2025.
  • CIBC Private Wealth Group sold 250 NewAmsterdam Pharma Warrant shares in Q4 2025, an estimated $6.2K.
  • NewAmsterdam Pharma Warrant made up ﹤0.01% of CIBC Private Wealth Group's portfolio in Q4 2025, its #2080 holding.
  • CIBC Private Wealth Group first reported a position in NewAmsterdam Pharma Warrant in Q1 2024 and has held it in 8 quarters since.
  • 9 funds tracked by Wall St. Rank held NewAmsterdam Pharma Warrant as of Q4 2025.

Based on CIBC Private Wealth Group's 13F filing for Q4 2025, filed 12 Feb 2026.